Harvard Scientific (HVSF)Hot$$- male impotency medicine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Wally who wrote (2842)	1/22/1998 10:19:00 AM
From: Tomas	Read Replies (1) of 3906

Wally remember one thing, for all practical purposes the drug that Harvard wants to use has already been FDA approved. What they are bringing to the table that is new is the manner in which it is administered and the encapsulation. Hopefully, and this seems to be the bet most folks are riding on, the Phase II and Phase III testing should move along a little faster, given the previous information generated about the drug. I do agree that $10M is pretty small potatoes for financing any company, let alone a bio-firm. Harvard does have access to there "Parent" company and its facilities, with Dr. See having a vested interest in both. Soooo, maybe its a go and maybe not. Tom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next